MET and breast cancer: For instance, the delivery of an oncolytic adenovirus expressing DCN blocks breast cancer cell growth and development of lung metastasis in a breast cancer mice model through multiple mechanisms involve inhibition of EMT, regulation of Wnt/β-catenin, VEGF and Met signaling as well as modulation of inflammatory and immune responses [61].